3.58
price down icon0.56%   -0.02
 
loading
Schlusskurs vom Vortag:
$3.60
Offen:
$3.59
24-Stunden-Volumen:
52,647
Relative Volume:
0.36
Marktkapitalisierung:
$135.18M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-27.66M
KGV:
-3.7684
EPS:
-0.95
Netto-Cashflow:
$-24.36M
1W Leistung:
+5.29%
1M Leistung:
+28.78%
6M Leistung:
-9.60%
1J Leistung:
+64.98%
1-Tages-Spanne:
Value
$3.55
$3.70
1-Wochen-Bereich:
Value
$3.26
$3.70
52-Wochen-Spanne:
Value
$1.60
$5.885

Genelux Corp Stock (GNLX) Company Profile

Name
Firmenname
Genelux Corp
Name
Telefon
805-267-9889
Name
Adresse
2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE
Name
Mitarbeiter
24
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
GNLX's Discussions on Twitter

Vergleichen Sie GNLX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
GNLX
Genelux Corp
3.58 124.61M 0 -27.66M -24.36M -0.95
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
473.84 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
569.27 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.03 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
581.51 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.51 31.99B 3.81B -644.79M -669.77M -6.24

Genelux Corp Stock (GNLX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-10-29 Eingeleitet Guggenheim Buy
2024-08-28 Eingeleitet ROTH MKM Buy
2023-11-27 Eingeleitet H.C. Wainwright Buy
2023-09-12 Eingeleitet Maxim Group Buy
2023-02-15 Eingeleitet The Benchmark Company Speculative Buy

Genelux Corp Aktie (GNLX) Neueste Nachrichten

pulisher
Jul 23, 2025

Genelux Corporation Stock Analysis and ForecastHigh-yield investments - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Genelux Corporation stock priceFree Buy/Sell Signal Notifications - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Genelux stock maintains Buy rating at H.C. Wainwright amid sector news By Investing.com - Investing.com South Africa

Jul 23, 2025
pulisher
Jul 23, 2025

Promising Prospects for Genelux Corp.’s Olvi-Vec: A Buy Rating Based on Strong Clinical Trial Design and Efficacy - TipRanks

Jul 23, 2025
pulisher
Jul 21, 2025

Lucid Capital Initiates Coverage on Genelux with a Buy Rating, Setting a Price Target of $10. - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Lucid Capital Initiates Coverage of Genelux with Buy Rating and $10 Price Target - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

What analysts say about Genelux Corporation stockFree Stock Selection - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

Lucid Capital Markets initiates Genelux stock with Buy rating, $10 target By Investing.com - Investing.com South Africa

Jul 21, 2025
pulisher
Jul 21, 2025

Genelux initiated with a Buy at Lucid Capital - TipRanks

Jul 21, 2025
pulisher
Jul 20, 2025

Is Genelux Corporation a good long term investmentExceptional portfolio growth - Autocar Professional

Jul 20, 2025
pulisher
Jul 19, 2025

Genelux Corp: A Promising Investment in the Oncolytic Virus Space with Key Clinical Milestones Ahead - TipRanks

Jul 19, 2025
pulisher
Jul 19, 2025

What risks could impact Genelux Corporation stock performanceExpert Trading Flow - Newser

Jul 19, 2025
pulisher
Jul 18, 2025

Genelux Corporation (NASDAQ:GNLX) Position Trimmed by Stratos Wealth Partners LTD. - Defense World

Jul 18, 2025
pulisher
Jul 15, 2025

Why Genelux Corporation stock attracts strong analyst attentionProven Win Setups - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Genelux Corporation stock price move sharplyFree VIP Investment Strategies - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

Genelux (NASDAQ:GNLX) Raised to “Hold” at Wall Street Zen - Defense World

Jul 12, 2025
pulisher
Jul 08, 2025

Amgen Alum Takes Legal Reins of Biotech Firm Developing Cancer Treatment - Law.com

Jul 08, 2025
pulisher
Jul 07, 2025

Genelux Appoints Groen as General Counsel From Rani Therapeutics - Bloomberg Law News

Jul 07, 2025
pulisher
Jul 07, 2025

Biopharma Co. Genelux Hires Life Sciences Veteran As GC - Law360

Jul 07, 2025
pulisher
Jul 07, 2025

Genelux appoints Eric Groen as general counsel, corporate secretary, CCO - TipRanks

Jul 07, 2025
pulisher
Jul 07, 2025

Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development - MarketScreener

Jul 07, 2025
pulisher
Jul 07, 2025

Former Amgen $10B Deal Architect Joins Genelux Leadership to Drive Strategic Growth - Stock Titan

Jul 07, 2025
pulisher
Jul 07, 2025

Genelux Corporation Appoints Eric Groen as General Counsel and Head of Business Development - Quiver Quantitative

Jul 07, 2025
pulisher
Jul 02, 2025

Genelux Corporation (NASDAQ:GNLX) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Jul 02, 2025
pulisher
Jun 16, 2025

June 2025's Promising Penny Stocks For Savvy Investors - simplywall.st

Jun 16, 2025
pulisher
Jun 14, 2025

Two Sigma Investments LP Sells 18,446 Shares of Genelux Co. (NASDAQ:GNLX) - Defense World

Jun 14, 2025
pulisher
Jun 12, 2025

Citadel Advisors LLC Lowers Position in Genelux Co. (NASDAQ:GNLX) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Millennium Management LLC Cuts Stake in Genelux Co. (NASDAQ:GNLX) - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Genelux Co. (NASDAQ:GNLX) Shares Sold by Squarepoint Ops LLC - Defense World

Jun 11, 2025
pulisher
Jun 08, 2025

Wall Street Zen Downgrades Genelux (NASDAQ:GNLX) to Sell - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

Genelux Co. (NASDAQ:GNLX) Given Average Recommendation of “Buy” by Brokerages - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Genelux (NASDAQ:GNLX) Trading Up 3.3% – Time to Buy? - Defense World

Jun 06, 2025
pulisher
Jun 02, 2025

Genelux Corporation (GNLX) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Jun 02, 2025
pulisher
May 14, 2025

Top Executives at Genelux Corp. Unload Thousands of Shares! - TipRanks

May 14, 2025
pulisher
May 13, 2025

GENELUX Corp Executives Sell Shares to Cover Taxes - TradingView

May 13, 2025
pulisher
May 10, 2025

Genelux Q3 EPS Raised by Brookline Capital Management - Defense World

May 10, 2025
pulisher
May 10, 2025

HC Wainwright Issues Optimistic Outlook for Genelux Earnings - Defense World

May 10, 2025
pulisher
May 09, 2025

Genelux Corp.’s Promising Prospects: Buy Rating Backed by Strong Phase 3 Trial and Financial Position - TipRanks

May 09, 2025
pulisher
May 08, 2025

Genelux (GNLX) Price Target Lowered by Benchmark Analyst | GNLX Stock News - GuruFocus

May 08, 2025
pulisher
May 07, 2025

Promising Developments in Genelux Corp.’s Olvi-Vec Drive Buy Rating - TipRanks

May 07, 2025
pulisher
May 07, 2025

H.C. Wainwright lifts Genelux stock target to $31, maintains buy By Investing.com - Investing.com Nigeria

May 07, 2025
pulisher
May 07, 2025

H.C. Wainwright lifts Genelux stock target to $31, maintains buy - Investing.com

May 07, 2025
pulisher
May 06, 2025

Genelux reports Q1 EPS (21c), consensus (24c) - TipRanks

May 06, 2025
pulisher
May 06, 2025

Genelux (GNLX) Shows Strong Progress in Cancer Treatment Trials | GNLX Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Genelux Reports 71% Disease Control Rate in Lung Cancer Trial, Q1 2025 Earnings | GNLX Stock News - Stock Titan

May 06, 2025
pulisher
May 06, 2025

Genelux Corporation Reports First Quarter 2025 Financial Results and Provides General Business Updates - Yahoo Finance

May 06, 2025
pulisher
May 02, 2025

Geode Capital Management LLC Has $716,000 Position in Genelux Co. (NASDAQ:GNLX) - Defense World

May 02, 2025
pulisher
May 01, 2025

Genelux CEO Discusses Next-Gen Immuno-Oncology Pipeline and Key Milestones at Citizens Conference - Stock Titan

May 01, 2025
pulisher
Apr 30, 2025

LPL Financial LLC Has $222,000 Stock Position in Genelux Co. (NASDAQ:GNLX) - Defense World

Apr 30, 2025
pulisher
Apr 18, 2025

Is EUROFINS SCIENT (ERFSF) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Apr 18, 2025
pulisher
Apr 14, 2025

Raymond James Financial Inc. Takes $41,000 Position in Genelux Co. (NASDAQ:GNLX) - Defense World

Apr 14, 2025

Finanzdaten der Genelux Corp-Aktie (GNLX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$23.52
price up icon 2.89%
$36.33
price up icon 0.84%
$102.86
price down icon 0.44%
$27.70
price down icon 0.89%
$114.09
price down icon 0.58%
biotechnology ONC
$294.51
price down icon 0.08%
Kapitalisierung:     |  Volumen (24h):